Cargando…

9. Coronaviruses: Development of Novel Oncolytic Vectors

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Gene Therapy. Published by Elsevier Inc. 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129012/ http://dx.doi.org/10.1016/j.ymthe.2005.06.012

Ejemplares similares

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2015)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023)

Species D Adenoviruses as Oncolytic Viral Vectors
por: Bullard, Brianna L., et al.
Publicado: (2020)

Development of Oncolytic Vectors Based on Human Adenovirus Type 6 for Cancer Treatment
por: Osipov, Ivan D., et al.
Publicado: (2023)

Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins
por: Hudacek, Andrew W., et al.
Publicado: (2013)

Oncolytic viruses on the cusp of success?: proceedings of the 9th International Conference on Oncolytic Virus Therapeutics
por: Peters, Cole, et al.
Publicado: (2016)

Characterization of an oncolytic adenovirus vector constructed to target the cMet receptor
por: Sakr, Hany I, et al.
Publicado: (2015)

The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
por: Young, Brittany A., et al.
Publicado: (2013)

Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
por: Tang, Chao, et al.
Publicado: (2022)

Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector
por: Budzik, Karol M., et al.
Publicado: (2022)

Coronavirus Reverse Genetics and Development of Vectors for Gene Expression
por: Enjuanes, L., et al.
Publicado: (2005)

Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy
por: Ravirala, Divya, et al.
Publicado: (2021)

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
por: Saari, Heikki, et al.
Publicado: (2020)

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
por: Ho, Tiffany Y., et al.
Publicado: (2021)

Two roads for oncolytic immunotherapy development
por: Kaufman, Howard L., et al.
Publicado: (2019)

Bovine herpesvirus 4 based vector as a potential oncolytic-virus for treatment of glioma
por: Redaelli, Marco, et al.
Publicado: (2010)

Immunomodulatory Arming Factors—The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules
por: Peters, Cole W. D., et al.
Publicado: (2021)

Enhanced Specific Delivery and Targeting of Oncolytic Sindbis Viral Vectors by Modulating Vascular Leakiness in Tumor
por: Tseng, Jen-Chieh, et al.
Publicado: (2009)

The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors
por: Young, Brittany A., et al.
Publicado: (2013)

Developing oncolytic Herpes simplex virus type 1 through UL39 knockout by CRISPR-Cas9
por: Ebrahimi, Saeedeh, et al.
Publicado: (2020)

ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)

Development and applications of oncolytic Maraba virus vaccines
por: Pol, Jonathan G, et al.
Publicado: (2018)

Advances in the design and development of oncolytic measles viruses
por: Hutzen, Brian, et al.
Publicado: (2015)

Correction: Two roads for oncolytic immunotherapy development
Publicado: (2021)

Developing Oncolytic Viruses for the Treatment of Cervical Cancer
por: Kalafati, Eleni, et al.
Publicado: (2023)

Properties of Adenovirus Vectors with Increased Affinity to DSG2 and the Potential Benefits of Oncolytic Approaches and Gene Therapy
por: Bahlmann, Nora A., et al.
Publicado: (2022)

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer
por: Mansfield, D C, et al.
Publicado: (2016)

Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer
por: Lucas, Tanja, et al.
Publicado: (2015)

Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector
por: Thomas, Michael A., et al.
Publicado: (2016)

Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates
por: Bots, Selas T.F., et al.
Publicado: (2022)

Development of a Safe and Effective Vaccinia Virus Oncolytic Vector WR-Δ4 with a Set of Gene Deletions on Several Viral Pathways
por: Mejías-Pérez, Ernesto, et al.
Publicado: (2017)

CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
por: Yuan, Ming, et al.
Publicado: (2016)

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
por: Deng, Lili, et al.
Publicado: (2017)

Novel oncolytic viral therapies in patients with thoracic malignancies
por: Ahmad, Zeeshan, et al.
Publicado: (2016)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
por: Liu, Hanmeng, et al.
Publicado: (2023)

Evaluation of a Novel Oncolytic Adenovirus Silencing SYVN1
por: Vermeulen, Christie, et al.
Publicado: (2022)

Evaluation of apoptogenic adenovirus type 5 oncolytic vectors in a Syrian hamster head and neck cancer model
por: Vijayalingam, S., et al.
Publicado: (2014)

Oncolytic viruses: A novel treatment strategy for breast cancer
por: Javanbakht, Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m51hdb1f4mvgmuuh6tcd1e9n44